Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 56

Results For "MP"

10704 News Found

Venus Remedies eceives GMP certification from Libya
News | January 18, 2024

Venus Remedies eceives GMP certification from Libya

The certification underscores Venus Remedies Limited's adherence to stringent quality control measures


Lupin Life hosted Second Edition of Aptivate Champion Run for Kids
News | January 15, 2024

Lupin Life hosted Second Edition of Aptivate Champion Run for Kids

The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars


Dr. Jitendra Singh launches AI supported Telemedicine Mobile Clinic in Udhampur
Healthcare | January 15, 2024

Dr. Jitendra Singh launches AI supported Telemedicine Mobile Clinic in Udhampur

The latest upgraded Tele Clinic is Artificial Intelligence (AI) - driven to provide healthcare facilities in far flung areas of the region, where such facilities are either not available or inadequately available


Lupin launches second edition of Aptivate Champion Run for Kids
News | January 09, 2024

Lupin launches second edition of Aptivate Champion Run for Kids

Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in Aptivate Champion Run


Supriya Lifesciences received GMP certification from ANVISA Brazil
News | January 06, 2024

Supriya Lifesciences received GMP certification from ANVISA Brazil

The clearance of this audit marks the successful registration of 8 APIs with CADIFA


Strides Pharma Science to invest in AMP-6, AMP-8
News | January 03, 2024

Strides Pharma Science to invest in AMP-6, AMP-8

AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka


Healthcare Triangle completes US$2 million private placement debt offering
Digitisation | January 03, 2024

Healthcare Triangle completes US$2 million private placement debt offering

The company received gross proceeds of approximately US$1.7 million and net proceeds,


Palatin completes sale of Vyleesi to Cosette Pharmaceuticals for up to $171 mn
News | January 02, 2024

Palatin completes sale of Vyleesi to Cosette Pharmaceuticals for up to $171 mn

Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)


Alkem completes sale of St. Louis manufacturing facility for US$ 7.96 million
News | December 31, 2023

Alkem completes sale of St. Louis manufacturing facility for US$ 7.96 million

The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year


Akums to empower mothers with Doxylamine + Pyridoxine extended-release tablets for severe morning sickness
News | December 28, 2023

Akums to empower mothers with Doxylamine + Pyridoxine extended-release tablets for severe morning sickness

This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy